Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.00 (0.00%)
Bid:
63.60
Ask:
68.60
Spread: 5.00 (7.862%)
Market Cap: £110.02m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Additional Listing

16 Nov 2017 12:20

RNS Number : 7341W
GCP Asset Backed Income Fund Ltd
16 November 2017
 

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815.Additional Listing

GCP Asset Backed, which invests in asset backed loans, has made an application for 120,619 ordinary shares of no par value each in the Company to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange. It is expected that these new ordinary shares will be admitted to trading on 24 November 2017.

The application is being made pursuant to the scrip dividend alternative in lieu of cash for the interim dividend for the period from 1 July 2017 to 30 September 2017 (the "Q3 Dividend"). Elections for a scrip dividend were received in respect of 3.43% of the ordinary shares in issue as at the record date of 27 October 2017. When issued, these new ordinary shares will rank pari passu with the existing ordinary shares.

Further details of the scrip dividend alternative can be found in the Scrip Dividend Circular 2017 which was published by the Company on 28 July 2017, a copy of which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at https://www.graviscapital.com/funds/gcp-asset-backed.

Following admission of the new ordinary shares, the Company's issued share capital will consist of 242,966,606 ordinary shares of no par value each and 75,000,000 C shares in issue. With effect from 24 November 2017, the total number of issued shares with voting rights will be 317,966,606.

The above figure of 317,966,606 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon david.conlon@graviscapital.com 

Philip Kent philip.kent@graviscapital.com 

Dion Di Miceli dion.dimiceli@graviscapital.com 

Cenkos Securities plc +44 (0)20 7397 8900

Tom Scrivens tscrivens@cenkos.com 

Oliver Packard opackard@cenkos.com 

Sapna Shah sshah@cenkos.com 

 

Buchanan +44 (0)20 7466 5000

Charles Ryland charlesr@buchanan.uk.com 

Victoria Hayns victoriah@buchanan.uk.com 

 

Notes to Editors 

The Company

GCP Asset Backed is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSGGGMGGUPMGPQ
Date   Source Headline
1st Jul 20194:04 pmRNSChange of Name Administrator and Company Secretary
28th Jun 20197:00 amRNSTotal Voting Rights
27th Jun 201911:47 amRNSHolding(s) in Company
25th Jun 20198:39 amRNSResult of Placing
13th Jun 20194:14 pmRNSNew Directorship Notification
4th Jun 20199:26 amRNSTotal Voting Rights & Additional Listing
24th May 20197:00 amRNSAdditional Listing
23rd May 20191:39 pmRNSProposed Placing of New Ordinary Shares
23rd May 20191:30 pmRNSResult of AGM & EGM
10th May 20192:06 pmRNSScrip Share Reference Price - Replacement
10th May 201912:17 pmRNSScrip Share Reference Price
1st May 20197:00 amRNSInvestor Report as at 31 March 2019
25th Apr 20194:11 pmRNSHolding(s) in Company
24th Apr 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Apr 20197:00 amRNSRevolving Credit Facility
11th Apr 20197:00 amRNSNet Asset Value(s)
10th Apr 20197:00 amRNSNotices of AGM & EGM
29th Mar 20197:00 amRNSAnnual Report & Financial Statements
29th Mar 20197:00 amRNSTotal Voting Rights
15th Mar 20192:57 pmRNSHolding(s) in Company
1st Mar 20199:55 amRNSTotal Voting Rights and Additional Listing
21st Feb 20197:00 amRNSAdditional Listing
7th Feb 20197:00 amRNSScrip Share Reference Price
31st Jan 20197:00 amRNSInvestor Report as at 31 December 2018
29th Jan 20193:54 pmRNSDirector/PDMR Shareholding
23rd Jan 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Jan 20197:00 amRNSPossible Equity Raise
17th Jan 20194:54 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSNet Asset Value(s)
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSConversion of C Shares
11th Dec 20187:00 amRNSResult of Placing
5th Dec 20187:00 amRNSProposed Placing of Ordinary Shares
30th Nov 20189:25 amRNSTotal Voting Rights & Additional Listing
28th Nov 20187:00 amRNSConversion of C Shares
21st Nov 20187:00 amRNSAdditional Listing
8th Nov 20187:00 amRNSScrip Share Reference Price
1st Nov 20187:00 amRNSInvestor Report as at 30 September 2018
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
15th Oct 20187:00 amRNSNet Asset Value(s)
10th Oct 20182:42 pmRNSTotal Voting Rights
2nd Oct 20183:50 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSResult of OO, Placing and OFS
28th Sep 20187:00 amRNSTotal Voting Rights
7th Sep 20181:13 pmRNSC Share Issue and publication of prospectus
5th Sep 20187:00 amRNSHalf-year Report & Financial Statements
3rd Sep 20189:00 amRNSAdditional Listing
22nd Aug 20187:00 amRNSAdditional Listing
21st Aug 201810:04 amRNSRevolving Credit Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.